Daniel Cohen
Amministratore Delegato presso Painscript Corp.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Clifford Saffron | M | 67 | 3 anni | |
Julie Dobson | F | 67 |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million. | - |
Ernest Stern | M | 73 |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million. | - |
Peter Joe Pitts | M | 65 |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million. | - |
Martin Mann | M | - |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million. | - |
Bruce A. Kehr | M | - |
Painscript Corp.
Painscript Corp. Internet Software/ServicesTechnology Services Part of Optimus Healthcare Services, Inc., Painscript Corp. is a medical treatment compliance platform that focuses on creating personalized pathways to support chronic care management interventions for patients suffering from opioid and other substance use disorders. The company is based in Rockville, MD. The platform is technology-based and clinically validated through nine separate published and peer-reviewed clinical trials. Painscript's approach is accessible and user-friendly via a digital platform, providing physicians and patients with daily, evidence-based telehealth monitoring interventions designed to improve patient compliance with treatment protocols, leading to better health outcomes and a reduction in related healthcare costs. Daniel L. Cohen has been the CEO of the company since 2019. Painscript was acquired by Optimus Healthcare Services, Inc. on March 24, 2021 for $4.50 million. | - |
Rene A. Braeckman | M | - | 8 anni | |
Timothy Sangiovanni | M | 40 | 7 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Dan Gladney | M | 70 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | - |
Don Harrison | M | 90 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 8 anni |
Jeffrey Gudin | M | 58 | 2 anni | |
Paul Klingenstein | M | 68 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 7 anni |
Russell W. Felkey | M | 73 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 3 anni |
Luke Evnin | M | 60 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 13 anni |
Anthony P. Jansz | M | 63 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 5 anni |
Peter M. Delange | M | 54 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | - |
Nick Ansari | M | 62 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 5 anni |
Tonya Dowd | F | - |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 1 anni |
Mark Bullivant | M | - |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | - |
Scott A. Shikora | M | - |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 1 anni |
Bradford C. Hancock | M | - |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 2 anni |
Lori McDougal | F | 62 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | - |
Dennis D. Kim | M | 54 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 1 anni |
Paul Hickey | M | 59 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 1 anni |
Tracy Woody | F | 54 | 1 anni | |
Ellen E. Koskinas | F | 56 |
EnteroMedics, Inc.
EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | 3 anni |
Matthew Casbon | M | - | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 27 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Daniel Cohen
- Contatti personali